Ackman raises stake in Valeant Pharma

Mon Nov 23, 2015 5:41pm EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Nov 23 (Reuters) - Bill Ackman's Pershing Square Capital Management raised its stake in Valeant Pharmaceuticals International Inc to 9.9 percent, making it the second largest shareholder in the company.

The hedge fund firm previously held a stake of 5.7 percent in the drug maker. (1.usa.gov/1LwwmGG) (Reporting by Shailesh Kuber in Bengaluru; Editing by Anil D'Silva)